Severe sleepiness and excess sleep duration induced by paroxetine treatment is a beneficial pharmacological effect, not an adverse reaction

Journal of Affective Disorders

Volumn 150, Issue 3, 2013, Pages 1209-1212

  Murata, Yusuke ^a   Kamishioiri, Yuko ^a   Tanaka, Kenji ^b   Sugimoto, Hiroko ^a   Sakamoto, Shoko ^a   Kobayashi, Daisuke ^b   Mine, Kazunori ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Beneficial pharmacological effect; Genetic polymorphisms; Hypersomnia; Paroxetine; SSRI

Indexed keywords

ANXIOLYTIC AGENT; CYTOCHROME P450 2D6; GENOMIC DNA; HYPNOTIC AGENT; PAROXETINE; SEROTONIN TRANSPORTER; TRANSCRIPTION FACTOR CLOCK;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENETIC ASSOCIATION; HUMAN; HYPERSOMNIA; JAPANESE; MAJOR DEPRESSION; MALE; MENTAL PATIENT; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME; SOMNOLENCE;

BENEFICIAL PHARMACOLOGICAL EFFECT; GENETIC POLYMORPHISMS; HYPERSOMNIA; PAROXETINE; SSRI;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ASIAN CONTINENTAL ANCESTRY GROUP; CIRCADIAN RHYTHM; CLOCK PROTEINS; CYTOCHROME P-450 CYP2D6; DEPRESSIVE DISORDER; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; PAROXETINE; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84888343709     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.05.040     Document Type: Article

References (28)

1. Fava, M., McCall, W.V., Krystal, A., Wessel, T., Rubens, R., Caron, J., Amato, D., Roth, T., 2006. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biological Psychiatry 59,1052-1060.
2. Green., B., 2003. Focus on paroxetine. Current Medical Research and Opinion 19, 13-21.
3. Guzmán-Marín, R., Suntsova, N., Stewart, D.R., Gong, H., Szymusiak, R., McGinty, D., 2003. Sleep deprivation reduces proliferation of cells in the dentate gyrus of the hippocampus in rats. Journal of Physiology 549, 563-571.
4. Kishi, T., Kitajima, T., Ikeda, M., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Okochi, T., Okumura, T., Tsunoka, T., Ozaki, N., Iwata, N., 2009. CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients. Neuromolecular Medicine 11, 53-57.
5. Lam, R.W., 2006. Sleep disturbances and depression: A challenge for antidepressants. International Clinical Psychopharmacology 21 (Suppl 1), S25-29.
6. Malberg, J.E., Eisch, A.J., Nestler, E.J., Duman, R.S., 2000. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience 20, 9104-9110.
7. Mayers, A.G., Baldwin, D.S., 2005. Antidepressants and their effect on sleep. Human Psychopharmacology 20, 533-559.
8. Meerlo, P., Mistlberger, R.E., Jacobs, B.L., Heller, H.C., McGinty, D., 2009. New neurons in the adult brain: The role of sleep and consequences of sleep loss. Sleep Medicine Reviews 13, 187-194.
9. Mirescu, C., Peters, J.D., Noiman, L., Gould, E., 2006. Sleep deprivation inhibits adult neurogenesis in the hippocampus by elevating glucocorticoids. Proceedings of the National Academy of Sciences of the United States of America 103, 19170-19175.
10. Murata, Y., Kobayashi, D., Imuta, N., Haraguchi, K., Ieiri, I., Nishimura, R., Koyama, S., Mine, K., 2010. Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome. Journal of Clinical Psychopharmacology 30, 11-17.
11. Novati, A., Roman, V., Cetin, T., Hagewoud, R., den Boer, J.A., Luiten, P.G., Meerlo, P., 2008. Chronically restricted sleep leads to depression-like changes in neuro-transmitter receptor sensitivity and neuroendocrine stress reactivity in rats. Sleep 31, 1579-1585.
12. Papakostas, G.I., 2008. Tolerability of modern antidepressants. Journal of Clinical Psychiatry 69 (Suppl E1), 8-13.
13. Perlis, M., Smith, M., Orff, H., 2002. Major Depressive Disorder (MDD) is associated with a primary defect within the serotonergic system. Sleep Medicine Reviews 6, 353-357.
14. Perlis, M.L., Giles, D.E., Buysse, D.J., Tu, X., Kupfer, D.J., 1997. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. Journal of Affective Disorders 42, 209-212.
15. Pigeon, W.R., Hegel, M., Unützer, J., Fan, M.Y., Sateia, M.J., Lyness, J.M., Phillips, C., Perlis, M.L., 2008. Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort? Sleep 31, 481-488.
16. Richardson, G.S., 2005. The human circadian system in normal and disordered sleep. Journal of Clinical Psychiatry 66 (Suppl 9), 3-9.
17. Roman, V., Walstra, I., Luiten, P.G., Meerlo, P., 2005. Too little sleep gradually desensitizes the serotonin 1A receptor system. Sleep 28, 1505-1510.
18. Sahay, A., Hen, R., 2007. Adult hippocampal neurogenesis in depression. Nature Neuroscience 10, 1110-1115.
19. Samuels, B.A., Hen, R., 2011. Neurogenesis and affective disorders. European Journal of Neuroscience 33, 1152-1159.
20. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C., Hen, R., 2003. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809.
21. Serretti, A., Benedetti, F., Mandelli, L., Lorenzi, C., Pirovano, A., Colombo, C., Smeraldi, E., 2003. Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 121B, 35-38.
22. Serretti, A., Cusin, C., Benedetti, F., Mandelli, L., Pirovano, A., Zanardi, R., Colombo, C., Smeraldi, E., 2005. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 137B, 36-39.
23. Srinivasan, V., Pandi-Perumal, S.R., Trakht, I., Spence, D.W., Hardeland, R., Poeggeler, B., Cardinali, D.P., 2009. Pathophysiology of depression: Role of sleep and the melatonergic system. Psychiatry Research 165, 201-214.
24. Tanaka, M., Kobayashi, D., Murakami, Y., Ozaki, N., Suzuki, T., Iwata, N., Haraguchi, K., Ieiri, I., Kinukawa, N., Hosoi, M., Ohtani, H., Sawada, Y., Mine, K., 2008. Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea. International Journal of Neuropsychopharmacology 11, 261-267.
25. Thase, M.E., 1999. Antidepressant treatment of the depressed patient with insomnia. Journal of Clinical Psychiatry 60 (Suppl 17), 28-31.
26. Thase, M.E., Haight, B.R., Richard, N., Rockett, C.B., Mitton, M., Modell, J.G., VanMeter, S., Harriett, A.E., Wang, Y., 2005. Remission rates following anti-depressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. Journal of Clinical Psychiatry 66, 974-981.
27. Tsuno, N., Besset, A., Ritchie, K., 2005. Sleep and depression. Journal of Clinical Psychiatry 66, 1254-1269.
28. Winokur, A., Gary, K.A., Rodner, S., Rae-Red, C., Fernando, A.T., Szuba, M.P., 2001. Depression, sleep physiology, and antidepressant drugs. Depression and Anxiety 14, 19-28.